Eugene

[email protected]

LATEST

BenevolentAI Acquires Facility for Artificial Intelligence-Enabled Drug Development
By

By
BenevolentAI, a London, UK-headquartered artificial intelligence (AI) company focused on drug development, has acquired a drug discovery and development facility on the Babraham Research Campus in Cambridge, UK for an…

West Appoints New Chief Digital and Transformation Officer
By

By
West Pharmaceutical Services, an Exton, Pennsylvania-headquartered manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has appointed Silji Abraham as senior vice president and chief digital and…

FDA Commissioner Updates FDA’s Plan to Improve Flu Vaccines, Incl. Manufacturing
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has outlined the agency’s plans to address ways to increase the effectiveness of influenza vaccines, including evaluating the selection of the…

MilliporeSigma Plans to Invest $49 Million in Manufacturing and Distribution in Asia
By

By
MilliporeSigma, the life-sciences business of Merck KGaA, plans to invest EUR 40 million ($49 million) over two years to build a manufacturing and distribution presence in Asia with investments in…

Gilead Sciences Wins Reversal of $2.54-Billion Ruling Over Hepatitis C Drugs
By

By
A federal district court judge has overturned a 2016 jury award of $2.54 billion against Gilead Sciences relating to patent-infringement litigation with Merck & Co. over Gilead’s two blockbuster hepatitis…

Lonza Expands Encapsulation and HPAPI Capabilities in North America
By

By
Lonza is expanding its late-stage clinical and commercial encapsulation capabilities for solid-oral and inhaled dosage forms in North America. As part of the expansion, the company will install a new…

Merck & Co. Acquires Oncolytic Biopharma Company Viralytics for $394 Million
By

By
Merck & Co. has agreed to acquire Viralytics, a Sydney, Australia-headquartered biopharmaceutical company focused on oncology, for $394 million. On completion of the transaction, Viralytics will become a wholly owned…

Gilead’s Kite Pharma, Sangamo in Gene-Editing Pact Worth up to $3.16 Billion
By

By
Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, and Sangamo Therapeutics, a Richmond, California-based biotechnology company, have partnered to use Sangamo’s zinc finger nuclease (ZFN) technology platform for developing ex vivo cell…

Roche To Acquire Health Tech Firm Flatiron Health for $1.9 Billion
By

By
Roche has agreed to acquire a full stake in Flatiron Health, a New York-headquartered healthcare technology and services company focused on oncology, for $1.9 billion. Roche now owns a 12.6%…

J&J, AstraZeneca, and Mylan Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Johnson & Johnson, AstraZeneca, and Mylan. Editor’s Note: This article was updated on a continuous basis…